(CercleFinance.com) – Fermentalg recorded a sharp increase on Wednesday on the Paris Stock Exchange, investors welcoming the strategic plan and the new objectives revealed by the microalgae specialist.
Defined under the leadership of its new general director, Pierre Josselin, the plan targets a turnover objective of at least 25 million euros by 2026, an increase of more than six compared to sales of ‘around four million euros at present.
Thanks to the dynamism of the omega-3 market, Fermentalg intends to quickly accelerate its sales and serve new customers, which should allow it to reach ten million euros in turnover in 2024.
To this end, Fermentalg says it has entered into an industrial partnership with the HuvePharma group, a specialist in animal and human food, which will thus ensure the production of its DHA Origins food range.
In addition, Nico Bonne – an executive with 22 years of experience in the international ingredients and omega-3 markets – will join the company in early 2024 as commercial director.
Finally, Fermentalg says it has initiated discussions with its strategic and financial partners in order to identify the best means to accelerate its growth and achieve economic and financial balance, which will require additional financial resources for 2025.
Following these announcements, the stock rose 5.7% on Wednesday on the Paris Stock Exchange, which did not prevent it from falling by around 82% since the start of the year.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Are you following this action?
Receive all the information on FERMENTALG in real time: